doripenem has been researched along with Bacterial Infections, Gram-Positive in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, NP; Pillar, CM; Sahm, DF; Shah, D; Torres, MK | 1 |
| Jacobus, NV; McDermott, LA; Snydman, DR | 1 |
| Flamm, R; Kaniga, K; Nandy, P; Samtani, MN | 1 |
| Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K | 1 |
| Friedland, I; Jasovich, A; Jiang, J; Kaniga, K; Lucasti, C; Umeh, O | 1 |
| Bell, JM; Jones, RN; Sader, HS; Stilwell, MG; Turnidge, JD | 1 |
| Fritsche, TR; Jones, RN; Sader, HS; Stillwell, MG | 1 |
| Dedhia, HV; McKnight, R | 1 |
| Amsler, K; Bush, K; Flamm, R; Foleno, B; Santoro, C | 1 |
| Armand-Lefevre, L; Drugeon, HB; Gjoklaj, M; Kitzis, MD; Lascols, C; Leclercq, R; Legrand, P; Lemire, A; Mérens, A; Miara, A; Moubareck, C; Muller-Serieys, C; Reverdy, ME; Roussel-Delvallez, M; Soussy, CJ | 1 |
2 review(s) available for doripenem and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Doripenem: position in clinical practice.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Cross Infection; Doripenem; Drug Interactions; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas Infections | 2009 |
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; France; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitals, Teaching; Humans; Microbial Sensitivity Tests | 2011 |
1 trial(s) available for doripenem and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Meropenem; Middle Aged; Prospective Studies; Thienamycins | 2008 |
7 other study(ies) available for doripenem and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; United States | 2008 |
In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2008 |
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
Topics: Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method | 2010 |
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.
Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam | 2017 |
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2009 |
Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
Topics: Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Enterococcus; Europe; Gram-Positive Bacterial Infections; Humans; Latin America; Microbial Sensitivity Tests; North America; Staphylococcus; Streptococcus | 2009 |
Comparison of broth microdilution, agar dilution, and Etest for susceptibility testing of doripenem against gram-negative and gram-positive pathogens.
Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 2010 |